Your provider may also consider contraindications, pregnancy status, medication interactions, personal and family history, prior treatment response and other clinical factors
review your medication's prescribing information with your licensed healthcare provider Key research context: A 2024 phase 2 RCT documented 2.6% hip and 2.1% lumbar spine BMD reduction in a specific semaglutide study population within 52 weeks
Participation in the program does not create any vested rights, and Amble Health shall have no liability for any such changes, suspension, or termination
For patients hoping for more affordable options, the timeline for generic competition is a key consideration
Patient-specific risk factors such as pre-existing conditions, lifestyle factors, and genetic predispositions may also play a role
a firm, steady motion is best